HPV検査とパップテストの市場レポート：2030年までの動向、予測、競合分析

HPV検査とパップテストの動向と予測

世界のHPV検査とパップテスト市場は、2024年から2030年までのCAGRが6.5%で、2030年までに推定75億米ドルに達すると予測されます。この市場の主な促進要因は、HPV症例の増加とそれに伴う子宮頸がんの増加、子宮頸がん検診の取り組みに対する意識の高まり、子宮頸がん研究開発プロジェクトに対する資金調達の増加です。世界のHPV検査とパップテスト市場の将来は、病院・診療所および検査施設市場における機会によって有望視されています。

HPV検査とパップテスト市場の洞察

Lucintelは、市場参入企業の投資が増加していること、膣がんに比べて子宮頸がんの発生が多いことから、子宮頸がん検診は予測期間中も引き続き大きなセグメントであると予測しています。

北米は、子宮頸がん早期発見への高い意識、確立された検診推奨、優れたヘルスケア償還環境が拡大を促進しているため、予測期間中も最大地域であり続けるでしょう。

よくある質問

Q1.市場規模は？

A1.HPV検査とパップテストの世界市場は、2030年までに推定75億米ドルに達すると予想されています。

Q2.市場の成長予測は？

A2.世界のHPV検査とパップテスト市場は、2024年から2030年にかけてCAGR 6.5％で成長すると予測されます。

Q3.市場の成長に影響を与える主な促進要因は？

A3.この市場の主な促進要因は、HPV症例の増加とそれに伴う子宮頸がんの増加、子宮頸がん検診の取り組みに対する意識の高まり、子宮頸がん研究開発プロジェクトに対する資金調達の増加です。

Q4.市場の主要セグメントは？

A4.世界のHPV検査とパップテスト市場の将来は、病院・診療所および検査施設市場における機会により有望であると思われます。

Q5.市場の主要企業は？

A5.HPV検査とパップテストの主要企業は以下の通りです。

• Abbott
• QIAGEN
• BD
• Quest Diagnostics
• Hologic
• F. Hoffmann-La Roche
• Femasys
• Arbor Vita
• NURX
• Seegene

Q6.今後、最大となる市場セグメントは？

A6.Lucintelは、子宮頸がん検診は、市場参入企業の産業への投資が増加していること、子宮頸がんは膣がんに比べて発生率が高いことから、予測期間中、より大きなセグメントであり続けると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は？

A7.北米は、子宮頸がん早期発見に対する高い認知度、確立された検診推奨、優れたヘルスケア償還環境が拡大を促進しているため、予測期間中も最大の地域であり続ける。

Q8.レポートのカスタマイズは可能？

A8.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界のHPV検査とパップテスト検査市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界のHPV検査とパップテスト市場の動向（2018～2023年）と予測（2024～2030年）
• 検査タイプ別の世界のHPV検査とパップテスト検査市場
  • パップテスト
  • HPV検査
• 製品別の世界のHPV検査とパップテスト検査市場
  • 機器
  • 消耗品
  • サービス
• アプリケーション別の世界のHPV検査とパップテスト検査市場
  • 子宮頸がん検診
  • 膣がん検診
• 最終用途別の世界のHPV検査とパップテスト検査市場
  • 病院と診療所
  • 研究室
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界のHPV検査とパップテスト検査市場
• 北米のHPV検査とパップテスト市場
• 欧州のHPV検査とパップテスト検査市場
• アジア太平洋のHPV検査とパップテスト検査市場
• その他地域のHPV検査とパップテスト検査市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 検査タイプ別の世界のHPV検査とパップテスト検査市場の成長機会
  • 製品別の世界のHPV検査とパップテスト検査市場の成長機会
  • アプリケーション別の世界のHPV検査とパップテスト検査市場の成長機会
  • 最終用途別の世界のHPV検査とパップテスト検査市場の成長機会
  • 地域別の世界のHPV検査とパップテスト検査市場の成長機会
• 世界のHPV検査とパップテスト検査市場における新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のHPV検査とパップテスト検査市場の能力拡大
  • 世界のHPV検査とパップテスト市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Abbott
• QIAGEN
• BD
• Quest Diagnostics
• Hologic
• F. Hoffmann-La Roche
• Femasys
• Arbor Vita
• NURX
• Seegene

HPV Testing and Pap Test Trends and Forecast

The future of the global HPV Testing and Pap Test market looks promising with opportunities in the hospitals & clinics and laboratories market. The global HPV Testing and Pap Test market is expected to reach an estimated $7.5 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are growing HPV cases and the ensuing rise in cervical cancer, increasing awareness of initiatives for screening for cervical cancer, and rising financing for cervical cancer research and development projects.

A more than 150-page report is developed to help in your business decisions.

HPV Testing and Pap Test by Segment

The study includes a forecast for the global HPV Testing and Pap Test by test type, product, application, end use, and region.

HPV Testing and Pap Test Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

• Pap Test
• HPV Test

HPV Testing and Pap Test Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Instruments
• Consumables
• Services

HPV Testing and Pap Test Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Cervical Cancer Screening
• Vaginal Cancer Screening

HPV Testing and Pap Test Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Laboratories
• Others

HPV Testing and Pap Test Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of HPV Testing and Pap Test Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies HPV Testing and Pap Test companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the HPV Testing and Pap Test companies profiled in this report include-

• Abbott
• QIAGEN
• BD
• Quest Diagnostics
• Hologic
• F. Hoffmann-La Roche
• Femasys
• Arbor Vita
• NURX
• Seegene

HPV Testing and Pap Test Market Insights

Lucintel forecasts that cervical cancer screening will remain the larger segment over the forecast period due to growing market participants' investments in the industry, and greater occurrences of cervical cancer compared to vaginal cancer.

North America will remain the largest region over the forecast period due to high awareness of cervical cancer early detection, well-established screening recommendations, and a good healthcare reimbursement environment are driving expansion.

Features of the Global HPV Testing and Pap Test Market

Market Size Estimates: HPV testing and pap test market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: HPV testing and pap test market size by various segments, such as by test type, product, application, end use, and region in terms of value ($B).

Regional Analysis: HPV testing and pap test market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different test type, product, application, end use, and regions for the HPV Testing and Pap Test market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the HPV Testing and Pap Test market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the HPV Testing and Pap Test market size?

Answer: The global HPV Testing and Pap Test market is expected to reach an estimated $7.5 billion by 2030.

Q2. What is the growth forecast for HPV Testing and Pap Test market?

Answer: The global HPV Testing and Pap Test market is expected to grow with a CAGR of 6.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the HPV Testing and Pap Test market?

Answer: The major drivers for this market are growing HPV cases and the ensuing rise in cervical cancer, increasing awareness of initiatives for screening for cervical cancer, and rising financing for cervical cancer research and development projects.

Q4. What are the major segments for HPV Testing and Pap Test market?

Answer: The future of the global HPV Testing and Pap Test market looks promising with opportunities in the hospitals & clinics and laboratories market.

Q5. Who are the key HPV Testing and Pap Test market companies?

Answer: Some of the key HPV Testing and Pap Test companies are as follows.

• Abbott
• QIAGEN
• BD
• Quest Diagnostics
• Hologic
• F. Hoffmann-La Roche
• Femasys
• Arbor Vita
• NURX
• Seegene

Q6. Which HPV Testing and Pap Test market segment will be the largest in future?

Answer: Lucintel forecasts that cervical cancer screening will remain the larger segment over the forecast period due to growing market participants' investments in the industry, and greater occurrences of cervical cancer compared to vaginal cancer.

Q7. In HPV Testing and Pap Test market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high awareness of cervical cancer early detection, well-established screening recommendations, and a good healthcare reimbursement environment are driving expansion.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the HPV Testing and Pap Test market by test type (pap test and HPV test), product (instruments, consumables, and services), application (cervical cancer screening and vaginal cancer screening), end use (hospitals & clinics, laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global HPV Testing and Pap Test Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global HPV Testing and Pap Test Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global HPV Testing and Pap Test Market by Test Type
  • 3.3.1: Pap Test
  • 3.3.2: HPV Test
• 3.4: Global HPV Testing and Pap Test Market by Product
  • 3.4.1: Instruments
  • 3.4.2: Consumables
  • 3.4.3: Services
• 3.5: Global HPV Testing and Pap Test Market by Application
  • 3.5.1: Cervical Cancer Screening
  • 3.5.2: Vaginal Cancer Screening
• 3.6: Global HPV Testing and Pap Test Market by End Use
  • 3.6.1: Hospitals & Clinics
  • 3.6.2: Laboratories
  • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global HPV Testing and Pap Test Market by Region
• 4.2: North American HPV Testing and Pap Test Market
  • 4.2.1: North American HPV Testing and Pap Test Market by Application: Cervical Cancer Screening and Vaginal Cancer Screening
  • 4.2.2: North American HPV Testing and Pap Test Market by End Use: Hospitals & Clinics, Laboratories, and Others
• 4.3: European HPV Testing and Pap Test Market
  • 4.3.1: European HPV Testing and Pap Test Market by Application: Cervical Cancer Screening and Vaginal Cancer Screening
  • 4.3.2: European HPV Testing and Pap Test Market by End Use: Hospitals & Clinics, Laboratories, and Others
• 4.4: APAC HPV Testing and Pap Test Market
  • 4.4.1: APAC HPV Testing and Pap Test Market by Application: Cervical Cancer Screening and Vaginal Cancer Screening
  • 4.4.2: APAC HPV Testing and Pap Test Market by End Use: Hospitals & Clinics, Laboratories, and Others
• 4.5: ROW HPV Testing and Pap Test Market
  • 4.5.1: ROW HPV Testing and Pap Test Market by Application: Cervical Cancer Screening and Vaginal Cancer Screening
  • 4.5.2: ROW HPV Testing and Pap Test Market by End Use: Hospitals & Clinics, Laboratories, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global HPV Testing and Pap Test Market by Test Type
  • 6.1.2: Growth Opportunities for the Global HPV Testing and Pap Test Market by Product
  • 6.1.3: Growth Opportunities for the Global HPV Testing and Pap Test Market by Application
  • 6.1.4: Growth Opportunities for the Global HPV Testing and Pap Test Market by End Use
  • 6.1.5: Growth Opportunities for the Global HPV Testing and Pap Test Market by Region
• 6.2: Emerging Trends in the Global HPV Testing and Pap Test Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global HPV Testing and Pap Test Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global HPV Testing and Pap Test Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott
• 7.2: QIAGEN
• 7.3: BD
• 7.4: Quest Diagnostics
• 7.5: Hologic
• 7.6: F. Hoffmann-La Roche
• 7.7: Femasys
• 7.8: Arbor Vita
• 7.9: NURX
• 7.10: Seegene